Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups

World Journal of Gastroenterology

Volumn 21, Issue 9, 2015, Pages 2759-2769

  Hester, Christina M ^a,b   Jala, Venkatakrishna R ^c   Langille, Morgan G I ^d   Umar, Shahid ^b,e   Greiner, K Allen ^a,b   Haribabu, Bodduluri ^c  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^c University of Louisville School of Medicine   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Butyrate; Colorectal cancer; Microbiota; Racial ethnic disparities; Short chain fatty acids

Indexed keywords

SHORT CHAIN FATTY ACID; BACTERIAL DNA; FATTY ACID; RNA 16S;

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; BACTERIUM IDENTIFICATION; BACTEROIDETES; CANCER MORTALITY; CAUCASIAN; CLINICAL ARTICLE; CLOSTRIDIUM; COLORECTAL CANCER; COPY NUMBER VARIATION; DEPENDENT VARIABLE; ETHNIC GROUP; ETHNICITY; FECES ANALYSIS; FECES MICROFLORA; FEMALE; FIRMICUTES; FOOD INTAKE; HISPANIC; HUMAN; INTESTINE FLORA; MALE; METAGENOME; MIDDLE AGED; OCCULT BLOOD; PH; PYROSEQUENCING; RACE DIFFERENCE; RUMINOCOCCACEAE; AGED; BACTERIUM; CHEMISTRY; CLASSIFICATION; COLORECTAL TUMOR; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; FECES; GENETICS; ISOLATION AND PURIFICATION; KANSAS; METABOLISM; METAGENOMICS; MICROBIOLOGY; MORTALITY; PILOT STUDY; RIBOTYPING; RISK FACTOR;

AFRICAN AMERICANS; AGED; BACTERIA; COLORECTAL NEOPLASMS; DNA, BACTERIAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FATTY ACIDS; FECES; FEMALE; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; KANSAS; MALE; METAGENOME; METAGENOMICS; MIDDLE AGED; PILOT PROJECTS; RIBOTYPING; RISK FACTORS; RNA, RIBOSOMAL, 16S;

EID: 84925438629     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i9.2759     Document Type: Article

References (40)

1. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642 [PMID: 9024315 DOI: 10.1053/gast.1997.v112.agast970594].
2. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437 [PMID: 10070942].
3. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover DC, Schuman LM. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603-1607 [PMID: 11096167].
4. Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, Sutton S, Cuzick J, Northover JM. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998; 42: 560-565 [PMID: 9616321 DOI: 10.1136/gut.42.4.560].
5. Winawer SJ, Zauber AG. Colonoscopic polypectomy and the incidence of colorectal cancer. Gut 2001; 48: 753-754 [PMID: 11358886 DOI: 10.1136/gut.48.6.753].
6. Müller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904-910 [PMID: 7486484].
7. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073].
8. Kim J, Artinyan A, Mailey B, Christopher S, Lee W, McKenzie S, Chen SL, Bhatia S, Pigazzi A, Garcia-Aguilar J. An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes. Ann Surg 2011; 253: 647-654 [PMID: 21475002 DOI: 10.1097/SLA.0b013e3182111102].
9. Day GE, Provost E, Lanier AP. Alaska native mortality rates and trends. Public Health Rep 2009; 124: 54-64 [PMID: 19413028].
10. Lanier AP, Day GE, Kelly JJ, Provost E. Disparities in cancer mortality among Alaska Native people, 1994-2003. Alaska Med 2008; 49: 120-125 [PMID: 18491804].
11. Yothers G, Sargent DJ, Wolmark N, Goldberg RM, O'Connell MJ, Benedetti JK, Saltz LB, Dignam JJ, Blackstock AW. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials. J Natl Cancer Inst 2011; 103: 1498-1506 [PMID: 21997132 DOI: 10.1093/jnci/djr310].
12. Howlader NA, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute; cited 2011 October 24. Available from: URL: http://seer.cancer.gov/csr/1975-2008/.
13. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6: 121-131 [PMID: 18180751 DOI: 10.1038/nrmicro1817].
14. Dai ZL, Wu G, Zhu WY. Amino acid metabolism in intestinal bacteria: links between gut ecology and host health. Front Biosci (Landmark Ed) 2011; 16: 1768-1786 [PMID: 21196263].
15. Kosiewicz MM, Zirnheld AL, Alard P. Gut microbiota, immunity, and disease: a complex relationship. Front Microbiol 2011; 2: 180 [PMID: 21922015 DOI: 10.3389/fmicb.2011.00180].
16. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 523-531 [PMID: 21844910 DOI: 10.1038/nrgastro.2011.133].
17. Mueller C, Macpherson AJ. Layers of mutualism with commensal bacteria protect us from intestinal inflammation. Gut 2006; 55: 276-284 [PMID: 16407387 DOI: 10.1136/gut.2004.054098].
18. Corr SC, Hill C, Gahan CG. Understanding the mechanisms by which probiotics inhibit gastrointestinal pathogens. Adv Food Nutr Res 2009; 56: 1-15 [PMID: 19389605 DOI: 10.1016/S1043-4526(08)00601-3].
19. Marchesi JR, Dutilh BE, Hall N, Peters WH, Roelofs R, Boleij A, Tjalsma H. Towards the human colorectal cancer microbiome. PLoS One 2011; 6: e20447 [PMID: 21647227 DOI: 10.1371/journal.pone.0020447].
20. Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011; 6: e16393 [PMID: 21297998 DOI: 10.1371/journal.pone.0016393].
21. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22: 299-306 [PMID: 22009989 DOI: 10.1101/gr.126516.111].
22. Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, Baselga J, Liu C, Shivdasani RA, Ogino S, Birren BW, Huttenhower C, Garrett WS, Meyerson M. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012; 22: 292-298 [PMID: 22009990 DOI: 10.1101/gr.126573.111].
23. Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang X, Jia W, Cai S, Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012; 6: 320-329 [PMID: 21850056 DOI: 10.1038/ismej.2011.109].
24. Zackular JP, Baxter NT, Iverson KD, Sadler WD, Petrosino JF, Chen GY, Schloss PD. The gut microbiome modulates colon tumorigenesis. MBio 2013; 4: e00692-e00613 [PMID: 24194538 DOI: 10.1128/mBio.00692-13].
25. O'Keefe SJ. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 2008; 24: 51-58 [PMID: 18043233].
26. Roy CC, Kien CL, Bouthillier L, Levy E. Short-chain fatty acids: ready for prime time? Nutr Clin Pract 2006; 21: 351-366 [PMID: 16870803].
27. O'Keefe SJ, Ou J, Aufreiter S, O'Connor D, Sharma S, Sepulveda J, Fukuwatari T, Shibata K, Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J Nutr 2009; 139: 2044-2048 [PMID: 19741203 DOI: 10.3945/jn.109.104380].
28. Vipperla K, O'Keefe SJ. The microbiota and its metabolites in colonic mucosal health and cancer risk. Nutr Clin Pract 2012; 27: 624-635 [PMID: 22868282 DOI: 10.1177/0884533612452012].
29. Ou J, Carbonero F, Zoetendal EG, DeLany JP, Wang M, Newton K, Gaskins HR, O'Keefe SJ. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013; 98: 111-120 [PMID: 23719549 DOI: 10.3945/ajcn.112.056689].
30. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010; 7: 335-336 [PMID: 20383131 DOI: 10.1038/nmeth.f.303].
31. Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, Beiko RG, Huttenhower C. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013; 31: 814-821 [PMID: 23975157 DOI: 10.1038/nbt.2676].
32. Bordonaro M, Lazarova DL, Sartorelli AC. Butyrate and Wnt signaling: a possible solution to the puzzle of dietary fiber and colon cancer risk? Cell Cycle 2008; 7: 1178-1183 [PMID: 18418037 DOI: 10.4161/cc.7.9.5818].
33. Ohigashi S, Sudo K, Kobayashi D, Takahashi O, Takahashi T, Asahara T, Nomoto K, Onodera H. Changes of the intestinal microbiota, short chain fatty acids, and fecal pH in patients with colorectal cancer. Dig Dis Sci 2013; 58: 1717-1726 [PMID: 23306850 DOI: 10.1007/s10620-012-2526-4].
34. Biddle A, Stewart L, Blanchard J, Leschine S. Untangling the Genetic Basis of Fibrolytic Specialization by Lachnospiraceae and Ruminococcaceae in Diverse Gut Communities. Diversity 2013; 5: 627-640 [DOI: 10.3390/d5030627].
35. Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ. Phylogenetic relationships of butyrateproducing bacteria from the human gut. Appl Environ Microbiol 2000; 66: 1654-1661 [PMID: 10742256].
36. Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ. Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 2002; 68: 5186-5190 [PMID: 12324374 DOI: 10.1128/AEM.68.10.5186-5190.2002].
37. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104: 13780-13785 [PMID: 17699621 DOI: 10.1073/pnas.0706625104].
38. Mariat D, Firmesse O, Levenez F, Guimarəes V, Sokol H, Doré J, Corthier G, Furet JP. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9: 123 [PMID: 19508720 DOI: 10.1186/1471-2180-9-123].
39. Remely M, Dworzak S, Hippe B, Zwielehner J, Aumüller E, Brath H, Haslberger A. Abundance and Diversity of Microbiota in Type 2 Diabetes and Obesity. J Diabetes Metab 2013; 4: 253 [DOI: 10.4172/2155-6156.1000253].
40. Payne AN, Chassard C, Zimmermann M, Müller P, Stinca S, Lacroix C. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 2011; 1: e12 [PMID: 23154580 DOI: 10.1038/nutd.2011.8].